You are here

Medtech investor Clearbridge Health plans Catalist IPO

It expects operating expenses to go up in the near term after IPO, and can't be certain that it will achieve profitability


CLEARBRIDGE Health, the medtech investor formerly known as Clearbridge Accelerator, is planning an initial public offering (IPO) on the Singapore Exchange.

Clearbridge Health, which was renamed in April, lodged a draft prospectus for a listing on the Catalist board last...

Market voices on: